Company profile
Acutus Medical, Inc.
OTC: AFIB · Healthcare · Medical - Devices
#542 of 1,418 Healthcare companies by revenuetop-quartile growth
EA Score
——FH —DQ 26GM —SS 32
v0.1 · 25/100 weight · pillars only
↑ revenue growth (YoY), operating margin · ↓ market scale, filing timeliness
Methodology →Revenue TTM
$20.2M
Rev growth YoY (TTM)
+375.7%
Net income (FY)
-$9.5M
Employees
85
as of 2026-08-30
Market cap
$3.0k
as of 2026-08-30
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$20.2M$20.2M2024
Net income-$9.5M-$9.5M2024
Operating income-$57.0k-$57.0k2024
Total assets$28.6M$28.6M2024
Liabilities$40.2M$40.2M2024
Equity-$11.6M-$11.6M2024
Revenue trend
FY2020 – FY2024 · USD
FY20
FY20
FY21
FY22
FY23
FY24
Revenue by segment
Filed disclosures · FY2024
By product
Disposables97%
Product and Service, Other3%
By geography
Not disclosed.
The read
What is Acutus Medical, Inc.’s revenue?
Acutus Medical, Inc. booked $20.2M in FY2024 revenue, growing 181% year over year — faster than most Healthcare companies we track, at a -47.4% net margin.
Peers · Healthcare
MaxCyte, Inc.48DSCYNEXIS, Inc.60CEvofem Biosciences, Inc.42DNutrition Management Services Company——Immix Biopharma, Inc.49DSpectral AI, Inc.39DNeighbors
San Diego →Key facts
CEOTakeo Mukai
SectorHealthcare
IndustryMedical - Devices
HeadquartersCarlsbad, CA
ExchangeOTC: AFIB
Employees85
IPO date2020-08-06
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.